Radiation boost before surgery? trial aims to shrink tumors better
NCT ID NCT07040956
Summary
This study is testing if adding a low dose of radiation to a combination of targeted and immunotherapy drugs works better than the drugs alone when given before surgery for operable head and neck cancer. The goal is to shrink the tumor more effectively to improve surgical outcomes and potentially reduce the risk of the cancer coming back. About 98 patients will be randomly assigned to receive either the three-part combination or just the two drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Radiation Oncology
RECRUITINGChengdu, Sichuan, 610000, China
Contact
Conditions
Explore the condition pages connected to this study.